Title : Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double-blind crossover trial.

Pub. Date : 2017 Mar

PMID : 27667324






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double-blind crossover trial. Nadolol insulin Homo sapiens
2 RESULTS: Compared with placebo, nadolol treatment reduced insulin sensitivity (79.7 +- 10.1 vs 99.6 +- 10.3 muL/kg fat-free mass min-1 (mU/L)-1 , P = .005). Nadolol insulin Homo sapiens
3 CONCLUSIONS: Nadolol significantly worsened insulin sensitivity, glycemia, and disposition index in patients with liver cirrhosis. Nadolol insulin Homo sapiens